[DPHARMA] QoQ Annualized Quarter Result on 31-Mar-2016 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
18-May-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
31-Mar-2016 [#1]
Profit Trend
QoQ- -19.09%
YoY- -12.55%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 312,940 318,542 317,210 317,880 270,680 241,705 203,814 32.91%
PBT 31,479 33,573 35,328 39,764 49,755 42,968 41,210 -16.36%
Tax -4,653 -9,580 -11,790 -8,452 0 -11,714 -11,576 -45.38%
NP 26,826 23,993 23,538 31,312 49,755 31,253 29,634 -6.39%
-
NP to SH 27,115 25,156 24,692 31,372 38,775 31,253 29,634 -5.72%
-
Tax Rate 14.78% 28.53% 33.37% 21.26% 0.00% 27.26% 28.09% -
Total Cost 286,114 294,549 293,672 286,568 220,925 210,452 174,180 39.00%
-
Net Worth 454,703 451,913 446,334 457,492 270,177 268,509 190,284 78.26%
Dividend
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Div 18,132 - 13,947 - 15,843 - 11,193 37.73%
Div Payout % 66.87% - 56.49% - 40.86% - 37.77% -
Equity
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Net Worth 454,703 451,913 446,334 457,492 270,177 268,509 190,284 78.26%
NOSH 278,959 278,959 278,959 278,959 278,959 278,959 139,915 58.07%
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin 8.57% 7.53% 7.42% 9.85% 18.38% 12.93% 14.54% -
ROE 5.96% 5.57% 5.53% 6.86% 14.35% 11.64% 15.57% -
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
RPS 112.18 114.19 113.71 113.95 162.30 144.93 145.67 -15.91%
EPS 9.62 8.60 8.44 11.24 19.17 18.72 21.18 -40.77%
DPS 6.50 0.00 5.00 0.00 9.50 0.00 8.00 -12.87%
NAPS 1.63 1.62 1.60 1.64 1.62 1.61 1.36 12.77%
Adjusted Per Share Value based on latest NOSH - 278,959
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
RPS 32.51 33.09 32.95 33.02 28.12 25.11 21.17 32.93%
EPS 2.82 2.61 2.56 3.26 4.03 3.25 3.08 -5.68%
DPS 1.88 0.00 1.45 0.00 1.65 0.00 1.16 37.77%
NAPS 0.4723 0.4694 0.4636 0.4752 0.2807 0.2789 0.1977 78.23%
Price Multiplier on Financial Quarter End Date
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Date 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 -
Price 1.98 2.06 2.04 2.55 2.62 2.72 2.65 -
P/RPS 1.76 1.80 1.79 2.24 1.61 1.88 1.82 -2.20%
P/EPS 20.37 22.84 23.05 22.67 11.27 14.51 12.51 38.20%
EY 4.91 4.38 4.34 4.41 8.87 6.89 7.99 -27.61%
DY 3.28 0.00 2.45 0.00 3.63 0.00 3.02 5.63%
P/NAPS 1.21 1.27 1.28 1.55 1.62 1.69 1.95 -27.14%
Price Multiplier on Announcement Date
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Date 24/02/17 21/11/16 22/08/16 18/05/16 23/02/16 24/11/15 25/08/15 -
Price 2.23 2.10 2.14 2.40 2.61 2.70 2.40 -
P/RPS 1.99 1.84 1.88 2.11 1.61 1.86 1.65 13.23%
P/EPS 22.94 23.29 24.18 21.34 11.23 14.41 11.33 59.70%
EY 4.36 4.29 4.14 4.69 8.91 6.94 8.83 -37.39%
DY 2.91 0.00 2.34 0.00 3.64 0.00 3.33 -8.55%
P/NAPS 1.37 1.30 1.34 1.46 1.61 1.68 1.76 -15.31%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment